J Korean Radiol Soc.  2002 Feb;46(2):115-118. 10.3348/jkrs.2002.46.2.115.

US-guided Percutaneous Transhepatic Biliary Drainage: Comparative Study of Right-sided and Left-sided Approach

Affiliations
  • 1Department of Diagnostic Radiology Inje University Sanggye Paik Hospital. kimyh@sanggyepaik.or.kr
  • 2Department of Diagnostic Radiology Inje University Ilsan Paik Hospital.

Abstract

PURPOSE
To compare the feasibility and safety of US-guided right and left percutaneous transhepatic biliary drainage (PTBD).
MATERIALS AND METHODS
Between March 1998 and May 1999, 32 patients underwent 36 US-guided right or left PTBD in referred order, alternatively. The causes of biliary obstruction were bile duct stone (n=2), bile duct carcinoma (n=10), carcinoma of the pancreas (n=9), GB carcinoma (n=7), metastasis to the porta hepatis (n=3), and carcinoma of the ampulla of vater (n=1). Technical success, procedure time, fluoroscopic time, and complications were evaluated.
RESULTS
PTBD was successful in 94% of both right and left approach. The average procedure time was 9.7+/-3.8 min. in the right approach and 9.6+/-3.1 min. in the left approach, respectively (p=0.794). The average fluoroscopic time were 3.9+/-2.4 min. in the right approach and 3.8+/-2.2 min. in the left approach (p=0.892). A major complication, bile peritonitis, occurred in one of 16 patient with right-sided approach. Minor complications occurred in six right (2 hemobilia, 3 tube malfunction, 1 cholangitis) and three left (1 hemobilia, 1 fever, 1 cholangitis) PTBD. There were no significant difference in the complication rates between right and left PTBD (p=0.729).
CONCLUSION
There were no significant differences in feasibility and safety in US-guided right and left PTBD.

Keyword

Bile ducts, percutaneous drainage; Bile ducts, US

MeSH Terms

Ampulla of Vater
Bile
Bile Ducts
Drainage*
Fever
Hemobilia
Humans
Neoplasm Metastasis
Pancreas
Peritonitis
Full Text Links
  • JKRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr